US Stock MarketDetailed Quotes
AEON AEON Biopharma
- 1.010
- +0.020+2.02%
Close Aug 14 16:00 ET
- 1.010
- 0.0000.00%
Post 20:02 ET
39.92MMarket Cap-97P/E (TTM)
1.020High0.980Low63.43KVolume1.000Open0.990Pre Close63.44KTurnover0.40%Turnover RatioLossP/E (Static)39.52MShares17.17052wk High-1.43P/B16.23MFloat Cap0.80052wk Low--Dividend TTM16.07MShs Float17.170Historical High--Div YieldTTM4.04%Amplitude0.800Historical Low1.000Avg Price1Lot Size
AEON Biopharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||||
| Cash flow from continuing operating activities | 19.52%-8.12M | 22.23%-8.6M | -10.09M | -11.06M | -25.15%-35.58M | -8.45M | -200.53%-28.43M | 78.85%-9.46M | -44.73M |
| Net income from continuing operations | 1,167.12%164.11M | -569.07%-118.02M | ---15.38M | ---17.64M | 5.54%-52.56M | ---34.56M | -69.04%-55.64M | -120.53%-32.91M | --160.32M |
| Operating gains losses | ---8.81M | --43.82M | ---- | ---- | ---- | ---- | ---- | 104.31%11.24M | ---260.84M |
| Depreciation and amortization | 4.35%24K | 0.00%25K | --23K | --25K | 2,166.67%68K | --32K | --3K | --0 | --1.26M |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---14.65M |
| Other non cash items | -11,320.10%-163.03M | 1,271.18%63.86M | --1.45M | --4.66M | -76.26%4.41M | --19.67M | 238.99%18.59M | -63.34%5.48M | --14.96M |
| Change In working capital | -178.86%-2.11M | -82.19%96K | --2.67M | --539K | 342.66%6.27M | --4.74M | -2.48%1.42M | 2,804.00%1.45M | --50K |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -593.33%-148K | --30K |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---7.39M |
| -Change in prepaid assets | 6,150.00%363K | 217.95%124K | ---6K | --39K | -136.26%-66K | ---51K | 555.00%182K | 97.84%-40K | ---1.86M |
| -Change in payables and accrued expense | -192.43%-2.53M | -120.00%-92K | --2.74M | --460K | 416.51%6.51M | --4.79M | -23.17%1.26M | -82.90%1.64M | --9.59M |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---323K |
| -Change in other working capital | 201.75%58K | 60.00%64K | ---57K | --40K | -569.23%-174K | ---5K | ---26K | ---- | ---- |
| Cash from discontinued investing activities | |||||||||
| Operating cash flow | 19.52%-8.12M | 22.23%-8.6M | ---10.09M | ---11.06M | -25.15%-35.58M | ---8.45M | -200.53%-28.43M | 78.85%-9.46M | ---44.73M |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | -80.00%-306K | -9K | 86.56%-170K | 98.92%-1.27M | -117.29M | ||||
| Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---1.69M |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | -80.00%-306K | ---9K | ---170K | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.54%-1.27M | ---36.53M |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---79.07M |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | -80.00%-306K | ---9K | 86.56%-170K | 98.92%-1.27M | ---117.29M |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | 25.00%10M | -16.67%5M | 8M | 6M | 198.67%40.51M | -3.99M | -44.80%13.56M | -66.44%24.57M | 73.21M |
| Net issuance payments of debt | 25.00%10M | -16.67%5M | --8M | --6M | 170.05%40.51M | ---3.99M | -40.27%15M | 159.46%25.11M | --9.68M |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --77.73M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | -165.62%-1.44M | 96.19%-541K | ---14.2M |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | 25.00%10M | -16.67%5M | --8M | --6M | 198.67%40.51M | ---3.99M | -44.80%13.56M | -66.44%24.57M | --73.21M |
| Net cash flow | |||||||||
| Beginning cash position | -66.77%1.56M | -47.08%5.16M | --4.69M | --9.75M | -74.57%5.13M | --22.2M | 218.91%20.17M | -93.35%6.32M | --95.13M |
| Current changes in cash | 190.36%1.88M | 28.83%-3.6M | ---2.09M | ---5.06M | 130.70%4.62M | ---12.46M | -208.64%-15.04M | 115.59%13.84M | ---88.8M |
| End cash Position | 32.23%3.44M | -66.77%1.56M | --2.6M | --4.69M | 90.05%9.75M | --9.75M | -74.57%5.13M | 218.91%20.17M | --6.32M |
| Free cash flow | 19.52%-8.12M | 22.23%-8.6M | ---10.09M | ---11.06M | -25.48%-35.89M | ---8.46M | -202.33%-28.6M | 79.62%-9.46M | ---46.42M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg